Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.
Chin B. Eap(Hôpital de Cery), Jacques Turgeon(Académie Nationale de Médecine), Étienne Lessard(National Research Council Canada), M.-A. Yessine(Université de Montréal), Pierre Baumann(University of Lausanne), Marlyse Brawand-Amey(Hôpital de Cery), Gilles O’Hara(Institut universitaire de cardiologie et de pneumologie de Québec)
Cited by 94
Related Papers
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
|Pharmacopsychiatry|2017|1.4k
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
|Pharmaceutics|2020|237
Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
|Annals of Pharmacotherapy|2013|186